Vitalibis, Inc.
VCBD
$0.0018
$0.000.00%
| Weiss Ratings | VCBD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | VCBD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | VCBD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -24.14 | |||
| Price History | VCBD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 12.50% | |||
| 30-Day Total Return | 50.00% | |||
| 60-Day Total Return | 1,700.00% | |||
| 90-Day Total Return | 1,700.00% | |||
| Year to Date Total Return | 1,700.00% | |||
| 1-Year Total Return | 1,700.00% | |||
| 2-Year Total Return | 1,700.00% | |||
| 3-Year Total Return | 500.00% | |||
| 5-Year Total Return | -96.40% | |||
| 52-Week High % Change | -10.00% | |||
| 52-Week Low % Change | 179,900.00% | |||
| Price | VCBD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.00 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Apr 15, 2024 | |||
| 52-Week High Price (Date) | Feb 18, 2025 | |||
| Valuation | VCBD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 622.56K | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.11 | |||
| Earnings Per Share Growth | -29.04% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 9.00 | |||
| Price/Book (Q) | -0.26 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | VCBD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 935.77M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | VCBD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 702 944 9620 | |||
| Address | 3960 Howard Hughes Parkway Las Vegas, NV 89169 | |||
| Website | www.vitalibis.com | |||
| Country | United States | |||
| Year Founded | 2014 | |||
| Profitability | VCBD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -1,088.34% | |||
| Profit Margin | -1,623.93% | |||
| Management Effectiveness | VCBD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -353.83% | |||
| Return on Equity | -- | |||
| Income Statement | VCBD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 243.60K | |||
| Total Revenue (TTM) | 243.60K | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | 125.60K | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -2.65M | |||
| Net Income (TTM) | -3.96M | |||
| Net Income Avl. to Common (TTM) | -3.96M | |||
| Total Revenue Growth (Q YOY) | 39.06% | |||
| Earnings Growth (Q YOY) | 99.56% | |||
| EPS Diluted (TTM) | -0.11 | |||
| EPS Diluted Growth (Q YOY) | 100.00% | |||
| Balance Sheet | VCBD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 4.30K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 365.10K | |||
| Total Preferred Equity (Q) | 0.00 | |||
| Total Equity (Q) | -1.49M | |||
| Current Ratio (Q) | 5.029 | |||
| Book Value Per Share (Q) | -$0.01 | |||
| Total Assets (Q) | 411.40K | |||
| Total Current Liabilities (Q) | 72.60K | |||
| Total Debt (Q) | 1.06M | |||
| Total Liabilities (Q) | 1.90M | |||
| Total Common Equity (Q) | -1.49M | |||
| Cash Flow | VCBD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 338.80K | |||
| Net Change in Cash (TTM) | -29.90K | |||
| Levered Free Cash Flow (TTM) | 374.70K | |||
| Cash from Operations (TTM) | -368.60K | |||
